Spin-off news

MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab

Alnylam Launches Alnylam P⁵x25 Strategy for Planned Transition to a Top Five Biotech in Market Capitalization Over Next Five Years

Alnylam Reports Positive Topline Results from HELIOS-A Phase 3 Study of Vutrisiran in Patients with hATTR Amyloidosis with Polyneuropathy

Dewpoint Announces Collaboration with Pfizer to Develop Potential Therapies for a Rare Form of Muscular Dystrophy

MODAG Initiates First-in-Patient Phase 1b Trial for Anle138b in Parkinson´s Disease